NAYA Biosciences Inc. Com...

NASDAQ: IVF · Real-Time Price · USD
1.56
-0.19 (-10.86%)
At close: Aug 15, 2025, 3:59 PM
1.58
1.28%
After-hours: Aug 15, 2025, 06:20 PM EDT

NAYA Biosciences Common Stock Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.64M 1.69M 1.43M 1.84M 1.58M 1.38M 974.89K 315.9K 348.02K 278.14K 235.32K 146.13K 162.6K 3.05M 218.87K 208.47K 684.52K
Cost of Revenue
1.04M 957.42K 988.47K 861.65K 850.23K 886.75K 580.97K 235.71K 231K 79.19K 248.98K 192.61K 64.96K 47.29K 20.42K 14.6K 62.74K
Gross Profit
592.26K 728.55K 444.69K 974.95K 726.05K 495K 393.93K 80.19K 117.02K 198.95K -13.66K -46.47K 97.64K 3M 198.46K 193.88K 621.78K
Operating Income
-17.11M -3.98M -1.3M -1.9M -946.37K -1.51M -886.29K -2.07M -2.31M -2.72M -2.53M -2.68M -2.7M 503.56K -2.27M -1.89M -1.56M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.00 34.00 48.00 225.00 62.00 n/a 2.42K 2.01K
Pretax Income
-17.4M -3.68M -1.6M -2.25M -1.59M -1.97M -1.25M -2.24M -2.55M -2.76M -2.55M -2.8M -2.77M 101.78K -2.48M -1.82M -2.45M
Net Income
-17.4M -3.62M -1.63M -2.25M -1.6M -1.99M -1.25M -2.24M -2.55M -2.77M -2.55M -2.8M -2.77M -141.53K -2.24M -1.82M -2.45M
Selling & General & Admin
2.55M 3.48M 1.51M 2.65M 1.44M 1.86M 1.26M 2.04M 2.33M 2.84M 2.32M 2.44M 2.69M 2.43M 2.42M 2.05M 2.12M
Research & Development
265.66K 484.78K n/a n/a 4.88K 5.91K 2.67K 83.85K 73.52K 73.83K 175.27K 190.76K 104.18K 63.76K 55.39K 31.02K 66.27K
Other Expenses
14.88M 743.47K 230.5K 230.34K 226.96K 141.6K 20.5K 19.71K 19.09K n/a 19.73K n/a n/a n/a n/a n/a n/a
Operating Expenses
17.7M 4.7M 1.75M 2.88M 1.67M 2M 1.28M 2.15M 2.42M 2.92M 2.51M 2.64M 2.8M 2.5M 2.47M 2.08M 2.18M
Interest Expense
311.27K 231.82K 273.63K 369.61K 181.29K 182.04K 352.08K 175.19K 216.59K 56.13K 1.76K 102.00 1.46K 186.46K 93.39K 91.13K 895.23K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
18.74M 5.66M 2.73M 3.74M 2.52M 2.89M 1.86M 2.38M 2.65M 3M 2.76M 2.83M 2.86M 2.54M 2.49M 2.1M 2.24M
Income Tax Expense
n/a -54.01K 29.26K n/a 1.84K 23.04K 1.89K 2.87K n/a 2.07K n/a 800.00 n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
1.39M 401.01K 323.83K 300.82K 316.82K 218.04K 148.07K 61.02K 51.88K 51.19K 50.65K 50.48K 50.21K 47.26K 43.6K 43.52K 41.2K
Shares Outstanding (Diluted)
1.39M 401.01K 323.83K 300.82K 316.82K 218.04K 148.07K 61.02K 51.88K 51.19K 50.65K 50.48K 50.21K 47.26K 43.6K 43.52K 41.2K
EPS (Basic)
-12.53 -9.04 -5.04 -7.44 -5.04 -9.15 -8.4 -36.72 -49.2 -54.05 -50.28 -55.44 -55.2 -2.99 -57.6 -40.8 -60
EPS (Diluted)
-12.53 -9.04 -5.04 -7.44 -5.04 -9.15 -8.4 -36.72 -49.2 -54.05 -50.28 -55.44 -55.2 -2.99 -57.6 -40.8 -60
EBITDA
-16.86M -3.21M -1.1M -1.65M -1.19M -1.65M -873.97K -2.04M -2.32M -2.63M -2.53M -2.8M -2.7M 367.6K -2.34M -1.69M -1.55M
EBIT
-17.09M -3.45M -1.33M -1.88M -1.41M -1.79M -894.47K -2.06M -2.33M -2.71M -2.55M -2.8M -2.77M 288.25K -2.39M -1.73M -1.56M
Depreciation & Amortization
234.46K 231.81K 230.5K 230.34K 226.96K 141.6K 20.5K 19.7K 19.09K 77.55K 19.73K -34.82K 72.45K 79.36K 46.42K 31.66K 8.65K